Comprehensive data for studying serum exosome microRNA transcriptome in Parkinson's disease patients.

Autor: Yu Z; Department of Neurology, Juntendo University Graduate School of Medicine, Tokyo, Japan., Saiki S; Department of Neurology, Juntendo University Graduate School of Medicine, Tokyo, Japan. ssaiki@md.tsukuba.ac.jp.; Department of Neurology, Institute of Medicine, University of Tsukuba, Ibaraki, Japan. ssaiki@md.tsukuba.ac.jp., Shiina K; Department of Neurology, Juntendo University Graduate School of Medicine, Tokyo, Japan., Iseki T; Department of Neurology, Juntendo University Graduate School of Medicine, Tokyo, Japan., Sasazawa Y; Department of Neurology, Juntendo University Graduate School of Medicine, Tokyo, Japan.; Division for Development of Autophagy Modulating Drugs, Juntendo University Faculty of Medicine, Tokyo, Japan.; Research Institute for Diseases of Old Age, Juntendo University Graduate School of Medicine, Tokyo, Japan., Ishikawa KI; Department of Neurology, Juntendo University Graduate School of Medicine, Tokyo, Japan., Nishikawa N; Department of Neurology, Juntendo University Graduate School of Medicine, Tokyo, Japan., Sako W; Department of Neurology, Juntendo University Graduate School of Medicine, Tokyo, Japan., Oyama G; Department of Neurology, Juntendo University Graduate School of Medicine, Tokyo, Japan., Hatano T; Department of Neurology, Juntendo University Graduate School of Medicine, Tokyo, Japan., Suzuki A; Department of Neurology, Juntendo University Graduate School of Medicine, Tokyo, Japan.; Department of Neurology, Institute of Medicine, University of Tsukuba, Ibaraki, Japan., Souma S; Department of Neurology, Juntendo University Graduate School of Medicine, Tokyo, Japan., Kataura T; Department of Neurology, Institute of Medicine, University of Tsukuba, Ibaraki, Japan., Hattori N; Department of Neurology, Juntendo University Graduate School of Medicine, Tokyo, Japan. nhattori@juntendo.ac.jp.; Division for Development of Autophagy Modulating Drugs, Juntendo University Faculty of Medicine, Tokyo, Japan. nhattori@juntendo.ac.jp.; Research Institute for Diseases of Old Age, Juntendo University Graduate School of Medicine, Tokyo, Japan. nhattori@juntendo.ac.jp.; Neurodegenerative Disorders Collaborative Laboratory, RIKEN Center for Brain Science, Saitama, Japan. nhattori@juntendo.ac.jp.
Jazyk: angličtina
Zdroj: Scientific data [Sci Data] 2024 Oct 15; Vol. 11 (1), pp. 1128. Date of Electronic Publication: 2024 Oct 15.
DOI: 10.1038/s41597-024-03909-6
Abstrakt: Parkinson's disease (PD), the second most prevalent neurodegenerative disorder, was classically attributed to alpha-synuclein aggregation and consequent loss of dopaminergic neurons in the substantia nigra pars compacta. Recently, emerging evidence suggested a broader spectrum of contributing factors, including exosome-mediated intercellular communication, which can potentially serve as biomarkers and therapeutic targets. However, there is a remarkable lack of comprehensive studies that connect the serum exosome microRNA (miRNA) transcriptome with demographic, clinical, and neuroimaging data in PD patients. Here, we present serum exosome miRNA transcriptome data generated from four cohort studies. Two of these studies include 96 PD patients and 80 age- and gender-matched controls, with anonymised demographic, clinical, and neuroimaging data provided for PD patients. The other two studies involve 96 PD patients who were evaluated both before and after one year of treatment with rasagiline, a widely prescribed anti-parkinsonism drug. Together, the datasets provide a valuable source for understanding pathogenesis and discovering biomarkers and therapeutic targets in PD.
(© 2024. The Author(s).)
Databáze: MEDLINE
Externí odkaz: